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Innate inﬂammationE1-deleted adenovirus (FG Ad) transducing vectors are limited for use in vivo by their induction of strong
innate and adaptive inﬂammatory responses. We have examined the contribution of the transgene cassette,
particularly the foreign promoter driving transgene expression, in the induction of innate inﬂammation using
a mouse ear model in which swelling is measured as a sensitive surrogate marker of the total innate
inﬂammatory response. The commonly used cytomegalovirus major immediate early (CMV) promoter led to
high-level swelling that was independent of transgene expression, while the Rous sarcoma virus and human
ubiquitin C promoters led to intermediate levels of swelling and the Ad E1A promoter or no promoter led to
equally low levels of swelling. Signiﬁcant swelling was induced by a virus in which the E1A promoter directed
pIX expression, supporting the possibility that activation of expression of Ad genes retained in the vector plays
an important role in the inﬂammatory response. Taken together, our ﬁndings support the idea that strong
foreign promoters likely play the limiting role in the induction of innate and adaptive immune responses that
limit the duration of transgene expression after transduction by FG Ad vectors.ol of Medicine, Department of
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Replication-defective ﬁrst-generation adenovirus (FG Ad) vectors,
typically derived from Ad5, have the E1 region replaced by a foreign
gene, most often under the control of the cytomegalovirus major
immediate early (CMV) promoter. These vectors have promise for
gene therapy, but are limited by their induction of strong adaptive
(Choi et al., 1993; Smith et al., 1993) and innate (Muruve et al., 1999)
immune responses.
In contrast to the high level of inﬂammation induced by
replication-defective Ad vectors, wild-type Ad5 frequently causes
asymptomatic infections in people with normal immune responses
(Strauss, 1984; Lichtenstein and Wold, 2004). The relatively modest
pathogenicity of the wild-type virus in immune-competent indivi-duals raises the question of why replication-defective Ad5 vectors are
so inﬂammatory. The three most obvious explanations, aside from the
very large vector doses used in gene therapy, are that 1) deleted viral
genes play an important role in inhibiting inﬂammation, 2) intro-
duced foreign sequences play an inﬂammatory role in the context of
the virus, and 3) use of Ad vectors in tissues not normally infected by
Ad5 leads to enhanced inﬂammatory responses.
Deletion of the Ad E1 genes signiﬁcantly increases the inﬂamma-
tory response provoked by the virus lacking foreign sequences, as
assayed using swelling induced after subdermal injection of viruses
into BALB/c mouse ears as a sensitive and readily measured surrogate
marker of the total inﬂammatory response (Schaack et al., 2004). In
the context of no introduced foreign sequence, E1A, E1B, and E3 play
important roles in inhibiting virally-induced innate inﬂammation,
albeit in a complicated manner (Schaack et al., 2004; Schaack, 2005).
The contributions of other Ad gene products and introduced foreign
sequences to ear swelling have not been addressed.
In this study, we have examined the role of the transgene cassette,
particularly the foreign promoter introduced to direct expression of
the transgene, in the induction of inﬂammation. We demonstrate that
the presence of the CMV promoter leads to induction of swelling in a
manner independent of transgene expression, regardless of whether
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protein (GFP), the “self” protein murine adipophilin (ADPH), or no
foreign protein is encoded by the virus. We also demonstrate that the
presence of other promoters leads to swelling that correlates well
with the strength of the promoter.Results
The genotypes of viruses used in this study are presented in Table 1
and the left end structure of the viruses is schematically presented in
Fig. 1.Fig. 1. Schematic of the Ad chromosome. (A) The entire Ad5 chromosome is presented
schematically. (B–D) The left end of the viral vector chromosomes are presented
schematically. (B) The CMV promoter was inserted in the leftward orientation in the
absence of a coding sequence. The RSV and UbC promoters were similarly introduced.
(C) The structure of the CMV promoter directing ADPH expression is shown. (D) For
viruses in which a gene was inserted and the E1A 243R coding sequence or E1A 243
coding sequence and E1B gene are retained, the insertion site is immediately
downstream of the packaging sequence. The entire E1A promoter and enhancer
(Hearing and Shenk, 1983) was used to direct E1A 243 expression, so the packaging
sequence is reiterated.Plaque size is dependent on foreign promoter introduced into the Ad
chromosome
Puriﬁed viruses containing strong foreign promoters with no
introduced genes and AdΔpTP E1A 12S (virus Q; the genotypes of all
viruses tested are presented in Table 1), which does not induce and
does inhibit ear swelling (Schaack et al., 2004), were used to infect
HEK 293-pTP cells to assay plaque formation (Fig. 2). In HEK 293 cells,
the CMV promoter is considerably stronger than the RSV promoter,
which is considerably stronger than the E1A promoter (Schaack et al.,
2001). The RSV and UbC promoters are expected to be of similar
strength.
As expected, a range of plaque sizes was seen for each of the
viruses. However, plaques formed by AdΔpTP E1A 12S (virus Q;
average plaque area in arbitrary units 100±68 (standard deviation))
were generally considerably larger than those formed by Ad-CMV
(virus G; average area 8.5±11 units; Fig. 2A and B). Plaques formed
by Ad-Ubp (virus L; average area 12±11 units) were similar in size to
those formed by Ad-CMV and Ad-RSV plaques (virus K; average area
38±25 units; Fig. 2C and D), were intermediate in size between those
induced by AdΔpTP E1A 12S and Ad-CMV. The differences in size
between plaques formed by Ad-Ubp and Ad-CMV were not statisti-
cally signiﬁcant while differences in all other pairwise comparisons
were highly signiﬁcant. Because plaque sizes roughly correlate
inversely with the strength of the promoter introduced into the
virus (compare Fig. 2 with data below) and larger plaques are more
efﬁciently counted, plaque titers underestimate the infectivity of
viruses containing strong promoters. For that reason, care was taken
to grow and purify viruses using as similar conditions as possible, and
particle numbers were used to normalize amounts of virus used.Table 1
Viruses used in this study are deleted for the pTP gene and the E1A 289R coding sequence
Virus Promoter Orientation Poly
A AdE1Apr E1A right −
B AdE1Apr pA E1A right +
C AdΔE1 – −
D AdCMVR pA CMV right +
E AdCMVR-LacZ CMV right +
F AdCMVR CMV right −
G AdCMVL CMV left +
H AdCMVL-GFP CMV left +
I AdCMVL-ADPH CMV left +
J AdCMVL-MetVal CMV left +
K AdRSVL RSV left +
L AdUbCL UbC left +
M AdCMVR-LacZ E1A CMV right +
N AdCMVL-GFP E1AE1B CMV left +
O AdCMVL-ADPH E3 CMV left +
P AdCMVL-ADPH CMV left +
Q AdΔpTP E1A 12S E1A, E1B right +
The orientation of the promoter is indicated by “R” (rightward, or normal E1A, orientation)
and “−“, respectively.
⁎ The transgene cassettes are inserted between the packing sequence and the E1A promoE1-deleted Ad induces modest ear swelling
Understanding the contribution of Ad vector components to the
induction of innate inﬂammatory processes requires determination
of the background induced by E1-deleted Ads devoid of foreign
sequences. We have used a mouse ear model in which innate
inﬂammation induced by Ads is monitored using swelling, a sensitive
surrogate marker that correlates well with inﬂammation (Moorhead
et al., 1999; Schaack et al., 2004).
We previously showed that deletion of the E1A and E1B genes
leads to a modest level of ear swelling (Schaack et al., 2004). To test
the effect of the E1A promoter on the innate inﬂammatory response to
Ad, we constructed a virus deleted for the E1A coding sequence as
well as the E1B gene. A poly A site was introduced immediately
downstream of the E1A promoter. This virus (virus B) induced a
modest level of ear swelling (Fig. 3), statistically identical to swelling
induced by a virus deleted for the entire E1 region (virus C). These
data raise the possibility that relatively weak promoters have
little effect on the induction of innate inﬂammatory responses by
Ad vectors.and are wild-type for other genes not indicated.
A Encoding E1A 243R E1B E3
− − − +
− − − +
− − − +
− − − +
LacZ − − +
pIX − − +
− − − +
GFP − − +
ADPH − − +
MetVal − − +
− − − +
− − − +
LacZ⁎ + − +
GFP⁎ + + +
ADPH − − +
ADPH − − −
E1A 243R, E1B + + +
or “L” (leftward orientation). The presence or absence of sequences is indicated by “+”
ter.
Fig. 2. Plaque sizes vary as a function of the promoter introduced into the virus. HEK 293 plates were infected in triplicate for plaque assays. After incubation for 8 days, plates were
stained with neutral red and plaques counted. The viruses used for plaquing and the numbers of plaques counted on the entire plate are listed above each panel (A–D). A
representative ﬁeld from each plate is shown. The estimated efﬁciencies of plaque counting, relative to 300ΔpTP 12S, were CMV 11%; RSV 37%; UbC 49%.
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Our primary hypothesis underlying this study was that strong
promoters contained within Ad vectors are primarily responsible for
the strong innate inﬂammatory response induced by the vector. In
particular, expression of the pIX gene, which is immediately adjacent
to the transgene cassette, was expected to be activated by the
enhancer present within the promoter-containing DNA fragment
introduced into the vector.
To test the effect of pIX expression on ear swelling, the E1A
promoter was introduced immediately upstream of the pIX gene in
the absence of an intervening poly A site. This virus (virus A, Table 1)Fig. 3. E1A promoter effects on ear swelling. Viruses A–C are deleted for E1A and E1B as
well as pTP. The data presented for virus A include previously published (Schaack et al.,
2004) as well as new data. Virus B is identical to virus A except that the SV40 poly A site
was inserted immediately downstream of the E1A promoter. In this and succeeding
ﬁgures, results are presented for swelling induced 24 h after subdermal injection of
BALB/c mouse ears, with background due to injection of buffer alone subtracted. The
numbers of ears analyzed were: virus A, 16; virus B, 8; virus C, 11.induced a signiﬁcantly greater innate inﬂammatory response than
did the viruses deleted for all of E1 or containing the E1A promoter
followed by a poly A site (Fig. 3; Pb0.0002 for both pairwise compa-
risons), in agreement with the results of Nakai et al. (2007).The CMV promoter induces high-level ear swelling
Adaptive immune responses to LacZ encoded by Ad vectors play an
important role in limiting the efﬁcacy of the vectors (Yang et al., 1996;
Chen et al., 1997). However, innate inﬂammatory responses induced
by Ad vectors that contain the CMV promoter are apparent within 24
h after injection (Moorhead et al., 1999; Muruve et al., 1999; Schaack
et al., 2004), prior to the development of an adaptive immune
response. We hypothesized that the CMV promoter, and not
transgene expression, is the major contributor to the induction of
early innate responses, speciﬁcally through CMV enhancer-dependent
activation of expression of Ad genes retained in the vector. To test this
hypothesis, we compared the inﬂammatory effects of viruses with the
E1 region replaced by the CMV promoter directing expression of no
transgene (virus D), LacZ (virus E), or pIX expression (virus F)
(Fig. 4A). The presence of the CMV promoter alone led to induction of
swelling that was statistically the same as that induced by the virus
encoding LacZ (PN0.9; Fig. 4B), suggesting that the CMV promoter
accounts for the majority of transgene cassette-dependent ear
swelling. Interestingly, the virus containing the CMV promoter
immediately adjacent to the pIX gene and lacking a poly A site
between the CMV promoter and the pIX promoter induced swelling
that was not different from that induced by the virus encoding LacZ or
the virus containing the CMV promoter with a poly A site between the
CMV promoter and the pIX gene.
Fig. 5. Dependence of swelling induced as a function of promoter. Viruses that are
isogenic except for the promoter introduced in place of the E1 region were tested for
induction of swelling. Results for virus F are from Fig. 4 and for virus B are from Fig. 3.
The numbers of ears analyzed were: virus G, 9; virus K, 8; virus L, 8; virus B, 8.
Fig. 4. Coding region has no apparent effect but CMV promoter orientation has a
signiﬁcant effect on induction of swelling. (A) Viruses D, E, and F contain the CMV
promoter in the rightward orientation. The numbers of ears analyzed were: virus D, 18;
virus E, 12; virus F, 6. (B) Viruses G-J contain the CMV promoter in the leftward (anti-
E1A) orientation. The numbers of ears analyzed were: virus F, 9; virus G, 6; virus H, 18;
virus I, 12.
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manner
E1-deleted viruses were constructed with the CMV promoter in
the leftward (anti-E1A) orientation directing expression of no
introduced cDNA (virus G) or of cDNAs encoding GFP (virus H) or
the “self” gene murine ADPH (virus I). In the absence of a cDNA,
downstream AUG codons that could be present in an mRNA are in
poor context for translation initiation (Kozak, 1987) and little or no
polypeptide synthesis should occur. To control for unintended
polypeptide synthesis, the strong translation initiation site from
pEGFP-N1 with codons for Met and Val followed by a termination
codonwas introduced behind the CMV promoter (virus J). Translation
initiation at the introduced AUG should inhibit initiation at down-
stream sites (Liu et al., 1984). Met–Val, rather than Met alone, was
encoded because the +4 position (position 1 of codon 2) contributes
to translation initiation efﬁciency (Kozak, 1987). A literature search
uncovered no evidence for an inﬂammatory effect of the dipeptide
Met–Val.
All of the viruses carrying the CMV promoter in the leftward
orientation induced swelling that was statistically equivalent (Fig. 4B;
PN0.5 for all pairwise comparisons). The effect of promoter
orientation was determined by comparison of swelling induced by
viruses with rightward-facing (Fig. 3A) and leftward-facing (Fig. 4B)
CMV promoters. The virus with the leftward-facing CMV promoter
directing ADPH expression yielded differences that were slightly
above statistical signiﬁcance for viruses with the CMV promoter in the
rightward orientation (Pb0.06–0.1 for the three comparisons) while
all other pairwise comparisons of viruses carrying leftward oriented
CMV promoters with the viruses carrying rightward oriented CMV
promoters were statistically signiﬁcant (Pb0.02–0.048). Comparison
of the combined results demonstrates that signiﬁcantly greater
swelling is induced when the CMV promoter is in the leftward than
rightward orientation (P=0.011).
Inﬂammation induced by other promoters introduced into the Ad
chromosome
To test the effect of the relative strength of the introduced
promoter on the induction of swelling by Ad vectors, promoters ofvarying strengths followed immediately by the SV40 poly A site were
inserted in place of the E1 region. Viruses containing the relatively
weak Ad E1A promoter in its normal, rightward, orientation (virus A)
or the strong RSV LTR (virus K) or human ubiquitin C (Ub; virus L)
promoters, both in the leftward orientation, induced swelling that, in
comparison with the CMV promoter (Fig. 5), correlated well with the
approximate strengths of the introduced promoters (Schaack et al.,
2001). The virus carrying the CMV promoter induced signiﬁcantly
increased swelling relative to each of the other promoters. Swelling
induced in the presence of the UbC and RSV promoters was not
statistically different (PN0.5), while the viruses carrying the UbC or
RSV promoters both induced signiﬁcantly greater swelling than the
virus carrying the E1A promoter with a poly A site (virus A)
(Pb0.0002 for both).
E1 genes have little effect on ear swelling induced by a virus carrying the
CMV promoter
E1A 243R inhibits type 1 interferon responses (Reich et al., 1988),
transcription of the IL-6 gene (Janaswami et al., 1992), and IL-6-
dependent transcriptional activation (Takeda et al., 1994). There are
likely additional roles of E1A in inhibiting innate immune responses
provoked by the virus. To test the effects of E1A 243R on Ad vector-
induced inﬂammation, swelling induced by viruses encoding LacZ
under the control of the CMV promoter with (virus M) or without
(virus E) co-expression of E1A 243R protein under its own promoter
was compared. E1A 243R expression had no effect on swelling (PN0.9;
Fig. 6).
E1A 243R acts in concert with the E1B proteins to inhibit swelling
(Schaack et al., 2004). To test whether E1B proteins in concert with
E1A 243R inhibit CMV promoter-dependent swelling, we constructed
a virus encoding GFP under the control of the CMV promoter
immediately upstream of the E1 region containing the wild-type
E1B gene and the modiﬁed E1A gene encoding E1A 243R only (virus
N). Swelling was partially reduced relative to viruses containing the
CMV promoter in the leftward orientation and lacking the E1 genes.
However, plaque assays carried out with the stock demonstrated
that approximately 20% of the virus had lost GFP expression. PCR
analysis demonstrated that the CMV–GFP cassette had been deleted
from the chromosomes of these viruses, apparently through repeated
sequences of the cis-acting packaging sequence ﬂanking the CMV–
GFP cassette (the viral cis-acting packaging sequence overlaps the E1A
promoter and was therefore present immediately in front of the E1A
coding sequence as well as immediately in front of the E1A 243R
Fig. 7. E3 does not inhibit swelling induced by a virus encoding ADPH under the control
of the CMV promoter. E1-deleted viruses encoding ADPH under the control of the CMV
promoter that are isogenic except for the presence or absence of E3 were tested for
induction of swelling. Results for virus H are from Fig. 3. The numbers of ears analyzed
were: virus H, 18; virus N, 12.
Fig. 6. E1 proteins do not inhibit ear swelling induced by Ad vectors containing the CMV
promoter. The virus encoding LacZ in the rightward orientation was modiﬁed to encode
E1A 243R and the virus encoding GFP in the rightward orientation was modiﬁed to
encode E1A 243R and the E1B proteins. The poly A site for all clones is immediately
downstream of the transgene coding sequence. Results for virus E are from Fig. 2A and
for virus G are from Fig. 3. The numbers of ears analyzed were: virus E, 12; virus L, 6;
virus G, 6; virus M, 14.
32 J. Schaack et al. / Virology 412 (2011) 28–35gene). Given that viruses deleted for the CMV–GFP cassette should
induce no swelling, it is likely that the high-level swelling that
occurred was caused by the vectors that maintained the CMV–GFP
cassette, and that the presence of the E1 genes has little or no effect on
ear swelling induced by the vector encoding GFP under the control of
the CMV promoter.
The role of the E3 region in inhibiting innate inﬂammation induced by
the CMV promoter
The E3 gene encodes a variety of proteins that act to inhibit innate
and adaptive immune responses (Horwitz, 2004; Lichtenstein et al.,
2004; Windheim, et al. 2004). To test the role of E3 in inhibiting CMV
promoter-dependent innate inﬂammation, viruses with the E1 region
replaced by the CMV promoter in the leftward orientation driving
expression of murine ADHP and either wild-type (virus O) or deleted
(virus P) for the E3 gene were tested (Fig. 7). The presence of the E3
gene had no effect on swelling induced (PN0.5).
Discussion
Strong innate and adaptive immune responses are induced by E1-
deleted Ad vectors and adaptive immune responses to both viral
(Yang et al., 1994) and transgene (Yang et al., 1996) antigens are
important in limiting vector efﬁcacy. Helper-dependent Ad vectors
induce innate immune responses that, for the inﬂammatory media-
tors examined, are similar to those induced by FG Ad vectors early
after transduction (Muruve et al., 2004). However, the innate
response remains high for FG vectors for a week or more in DBA/2
mice while it declines for hd vectors. The fact that hd Ad vectors
effectively transduce tissues in vivo for extended periods of time
(Chen et al., 1997;Morsy et al., 1998; Toietta et al., 2005) suggests that
transient innate immune responses do not necessarily limit the
effectiveness of Ad vectors. However, innate responses prime the
adaptive immune responses to vector-encoded proteins, including the
transgene product. Therefore, it is important to understand the
induction of innate inﬂammatory responses by Ad vectors, especially
widely used FG vectors.Enhancer effects
The presence of the CMV promoter or other strong promoters in
the virus induces substantial ear swelling (Fig. 4) as well as activation
of expression of Ad genes retained in the vector (Shapiro et al., 2006
and Schaack et al., accompanying manuscript). Our underlying
hypothesis for these effects is that the enhancer contained within
the CMV promoter fragment is responsible for these effects.
Enhancers have come to be deﬁned as elements that act in a
position- and orientation-independent manner to activate transcrip-
tion, although this deﬁnition is simplistic. The prototypical, and by far
best studied, enhancer is that of SV40. The SV40 enhancer displays
modest orientation- and signiﬁcant position-dependent activity
(Wasylyk et al., 1984; Zenke et al., 1986). This is important in
consideration of the consistency of our results with our primary
hypothesis. The CMV promoter in the leftward orientation places the
pIX promoter immediately adjacent to the enhancer. In contrast, the
rightward orientation places the CMV promoter between the CMV
enhancer and the pIX promoter, so it is possible that the reduced
innate response induced by pIX results from dilution of enhancer
activity by the intervening CMV promoter. Alternatively, the CMV
enhancer may exhibit orientation dependence in its activity, a
possibility that literature searches did not indicate to have been
tested. An additional uncertainty arises from the fact that Ad
chromosome is bound by Ad core proteins, at least for a signiﬁcant
time after virus uptake by the cell (Chatterjee et al., 1986; Chen et al.,
2007). It is not clear how Ad chromatin affects the function of
enhancers compared to the effects of host cell and native viral
chromatin, although it is possible that the CMV promoter alters Ad
chromatin structure as it does in CMV DNA (Nitzsche et al., 2008).
CMV promoter induction of innate inﬂammatory processes
It is possible that increased and inappropriate expression of Ad
genes is responsible for the increased innate inﬂammation. The
mechanisms by which Ad early gene products contribute to the
induction of innate inﬂammatory processes remain to be determined,
but pIX, as suggested by Nakai et al. (2007), and possibly other Ad
proteins, could be at least partly responsible. Our evidence suggests
that pIX expression explains only part of the innate inﬂammatory
response. Positioning of the E1A promoter to direct pIX expression led
to a substantial increase in ear swelling. In contrast, positioning of the
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swelling compared to that induced when a poly A site was placed
between the CMV promoter and the pIX gene (Fig. 4A), and the level
of ear swelling induced is not maximal, as placement of the CMV
promoter in the opposite orientation led to a signiﬁcant increase in
swelling (Fig. 4B).
E4-dependent activation of TAp73 expression
Shapiro et al. demonstrated that transduction of BALB/c MEFs with
Ad vectors containing the CMV promoter led to increased TAp73
expression in an E4 orf6/7-dependent manner that was independent
of transgene expression (Shapiro et al., 2006). TAp73 expression was
induced to a greater extent when the CMV promoter was in the
leftward than the rightward orientation. When compared with data
presented here (Fig. 4), this suggests a possible correlation between
TAp73 induction in vitro and activation of innate inﬂammatory
processes in vivo, although it is not clear what mechanism(s) are
involved. Induction of TAp73 expression does not correlate com-
pletely with the inﬂammatory potential of the virus. Virus A,
containing the E1A promoter but lacking a poly A site before the
pIX gene, induced swelling that was similar to that induced by virus J,
containing the UbC promoter (compare Figs. 2 and 4). In contrast, a
virus containing the UbC promoter directing GFP expression induced
TAp73 to a lesser extent than did virus A inMEFs. In addition, the virus
containing a poly A site between the pIX gene and the E1A promoter
also induced TAp73 expression to a higher level than did the more
inﬂammatory virus containing the UbC promoter (Shapiro et al.,
2006).
Finally, the fact that the presence of the CMV promoter led to
greater TAp73 expression than did the UbC promoter in MEFs while
the presence of the UbC promoter led to greater activation of TAp73
expression than did the CMV promoter in human foreskin ﬁbroblasts
suggests that control of expression of Ad genes retained within
vectors is complex, with potential variability dependent on host cells
transduced.
Potential unintended consequences of gene deletions
pIX is normally expressed only after the onset of viral DNA
replication (Crossland and Raskas, 1983). The pIX gene is nested
within the 3' end of the E1B transcription unit and the pIX promoter is
normally inhibited prior to Ad DNA replication in part through
promoter occlusion dependent on transcription from the E1B
promoter (Vales and Darnell, 1989). E1B promoter activity is also
regulated, although in a positive manner, by read-through transcrip-
tion directed by the upstream E1A promoter (Parks and Spector,
1990; Shen and Spector, 2003). The transcription-regulatory mech-
anisms raise the possibility that pIX expression in cells transduced by
E1-deleted Ads could result, at least in part, from deletion of the E1A
and E1B promoters as well as from activation by strong foreign
enhancers.
The contribution of transgene expression to innate and adaptive
inﬂammatory processes
Our results indicate that induction of innate immune responses by
Ad vectors in the ﬁrst 24 h after transduction exhibits little or no
dependence on expression of a transgene or, among the three
transgenes that we tested, on the nature of the transgene. (Fig. 4).
However, other lines of experimentation have indicated that the
transgene product plays an important role in limiting the efﬁcacy of
Ad vectors.
Introduction of Ad vectors encoding LacZ into mice transgenic for
LacZ led to increased time of vector-mediated LacZ expression and
blunted adaptive immune responses to the vector compared totransduction of mice in which LacZ was a foreign protein (Yang et al.,
1996; Chen et al., 1997). This evidence led to the conclusion that the
transgene product plays the most important role in limiting E1-
deleted Ad vector effectiveness. However, AAV vectors permit
prolonged LacZ expression (Clemens et al., 1996; Kessler et al.,
1996; Rolling et al., 1997), indicating that LacZ that does not play the
limiting role in cessation of transgene expression in cells transduced
by Ad vectors. An alternative explanation, consistent with our model
of the effects of the CMV promoter on activation of innate immune
responses, is that CMV promoter-dependent activation of Ad vector
genes leads to induction of innate immune responses that efﬁciently
prime the adaptive immune response to LacZ, which is expressed at
extremely high levels when under the control of the CMV promoter.
Thus, while adaptive immunity to LacZ limits vector efﬁcacy, the CMV
promoter likely acts at the limiting step in induction of the innate
inﬂammatory response that leads to the adaptive immune response to
LacZ.
In a second experimental approach, the use of tissue-speciﬁc
promoters led to increased time of transgene expressionwith reduced
adaptive immune response directed against the vector relative to the
strong and broadly active PGK (Pastore et al., 1999) and CMV (Ding
et al., 2002) promoters. This ﬁnding led to the suggestion that
expression of the transgene in cells, particularly dendritic cells and
macrophages (Zhang et al., 2001), contributes to the adaptive
immune response to vector-transduced cells and limits the efﬁcacy
of the vector. Our results suggest an additional mechanism of
importance in the function of vectors that carry tissue-speciﬁc
promoters. Tissue-speciﬁc promoters are generally much weaker
than the CMV promoter/enhancer and are likely to induce lesser
expression of Ad genes retained in the vector in both the targeted cells
and in cells that efﬁciently prime adaptive immune responses.
Reduced expression of Ad genes likely leads to reduced innate
immune responses and thus to reduced adjuvant activity as well as
delayed and reduced adaptive immune responses to both the vector
and the transgene product. Data generated by Nakai et al. (2007)
support these possibilities. When the CMV promoter was used,
expression of the transgene was short lived. In contrast, when the
broadly active EF1α promoter was used, transgene expression was
prolonged. However, the EF1α promoter directed transgene expres-
sion at a level of approximately 10% of that directed by the CMV
promoter. These data support the argument that it is the strength of
the promoter, including the enhancer, that acts at the limiting step of
transgene expression.Plaque sizes and viruses that induce high levels of swelling
The size of plaques formed by the different viruses (Fig. 2)
inversely correlates with the amount of swelling induced after ear
injection. Smaller plaque size indicates that the virus grows more
slowly in complementing HEK 293 cells and this correlates with
greater induction of inﬂammation in vivo. It is possible that the
mechanisms that lead to increased inﬂammation in the presence
of strong promoters are the same as, or at least overlap, the mecha-
nisms that lead to reduced growth rate in vitro. Inappropriate level
or timing of expression of Ad genes is likely to be responsible for
both effects.
Small, more difﬁcult to count, plaques produced by the more
inﬂammatory viruses lead to underestimation of plaque titers in a
manner correlating with the level of inﬂammation induced by the
virus. Thus, plaque titers do not necessarily offer an appropriate
method of normalizing the amount of the virus. However, the use of
plaque titers would not have affected the general results obtained or
the conclusions drawn from these studies: themore inﬂammatory the
virus, the larger the amount of the virus that would have been used,
leading to even greater differences in ear swelling.
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Host innate and adaptive immune responses that limit the efﬁcacy
of Ad vectors have been studied in detail. However, the mechanisms by
which Ad vector components, particularly the genes retained within
the vector, induce inﬂammation remain poorly understood, and this
lack of understanding has impeded attempts to design improved simple
Ad gene therapy vectors. The demonstration that strong foreign
promoters, and especially the widely used CMV promoter, are
responsible for the majority of the strong innate response induced by
Ad vectors offers a promising avenue for understanding the mecha-
nisms by which innate inﬂammation is induced and for the design of
improved Ad vectors (see accompanying manuscript).
Materials and methods
Cell lines
HEK293 cells (Graham et al., 1977) and HEK293-pTP cells (Schaack
et al., 1995; Schaack et al., unpublished), which constitutively express
Ad pTP, were grown in DMEM containing high glucose supplemented
with 10% bovine calf serum.
Construction and growth of viruses
Viruses (Table 1) were constructed using the method of He et al.
(1998) as previously modiﬁed (Orlicky and Schaack, 2001). The
plasmids pShuttleE1A (Schaack et al., 2001), pShuttle, pShuttleCMV,
and pAdTrack (He et al. 1998) were described previously. New shuttle
plasmids containing the CMV, RSV, and Ub promoters in the leftward
(anti-E1A) orientation followed by the SV40 poly A signal (a generous
gift of David Orlicky) were constructed. The resultant plasmids are
pShuttleCMV rev, pShuttleRSV rev, and pShuttle-Ub rev, respectively.
The plasmid pShuttleE1A pA was constructed by insertion of the SV40
poly A site immediately downstream of the E1A promoter. Themurine
ADPH cDNA was introduced into pShuttleCMV rev to generate
pShuttleCMV-ADPH. Sequence including the very strong translation
start site from the plasmid pEGFP-N1 (Clontech) and encoding Met–
Val followed by a nonsense codon was synthesized by PCR and
inserted into pShuttleCMV rev to generate pShuttleCMV-Met–Val.
pShuttleCMV-LacZ/E1A 243R was constructed by introduction of the
Ad2 E1A 12S cDNA (encoding the 243R protein) into pShuttleE1A. The
CMV promoter followed by poly A site was introduced in the leftward
orientation between the E1A enhancer/packaging sequence and the
E1A promoter and the LacZ coding sequence followed by the SV40
poly A site was introduced immediately downstream of the CMV
promoter. To introduce a CMV–GFP expression cassette into the virus
deleted for the E1A 289R and pTP coding sequences, sequence
encoding the E1A enhancer, promoter, and E1A 243R coding sequence
in normal orientation was introduced into pShuttleCMV–GFP rev. The
plasmid was transferred to an E. coli dam- strain and DNA digested
with PacI+ClaI to liberate the desired viral left end fragment. DNA
prepared from the virus deleted for the E1A 289R and pTP coding
sequences was digested with ClaI and the large viral DNA fragment
puriﬁed by centrifugation on a 10–40% sucrose gradient and ligated
with the left end fragment containing the CMV–GFP expression
cassette as well as the majority of the E1A 243R coding sequence.
PmeI-linearized shuttle plasmids were used to transform E. coli
strain BJ5183 carrying pAdEasy-300Δ or pAdEasy-327ΔpTP (deleted
for the E3 region) to generate recombinant plasmids containing the
Ad chromosomes. Ad chromosomes were released from plasmids by
digestion with PacI and used to transfect HEK293-pTP cells using
calcium phosphate coprecipitation (Jordan et al., 1996) to generate
viruses. Viruses were plaque puriﬁed and tested by PCR, restriction
digestion, and, where appropriate, for expression of the transgene to
ensure the correct structure and genotype.Viruses were grown and puriﬁed by consecutive step and isopycnic
CsCl gradient centrifugation as previously described (Schaack et al.,
2004). Viral particle titers were determined by OD260, with one
OD260=1012 particles/ml. All virus stocks used in this study had less
than 1 infectious particle in 1011 particles when assayed on 293 cells.
Analysis of plaque sizes
Digital images taken of plaque plates were converted to TIFF ﬁles.
Plaque sizes were determined from the TIFF ﬁles using the masking
function of Slidebook (Intelligent Imaging Innovatiions, Denver CO).
Statistical signiﬁcance was determined using the two-tailed T test.
Injections of mice and analysis of swelling
All procedures involving animals followed the guidelines of, and
were approved by, the University of Colorado Institutional Animal Care
and Use Committee. Female, 6-week-old BALB/c mice were anesthe-
tized by intraperitoneal injection of avertin prior to all procedures.
Virus stocks were diluted with PBS such that the glycerol concentration
was 5%. 2×1011 puriﬁed particles in 10 μl were injected subdermally
into ears. Particle titerswere used because viruses differed substantially
in the rate of growth of plaques (Fig. 2) and thus in the accuracy with
which plaque titers could be determined. Care was taken to prepare
and purify virus stocks under identical conditions to ensure that particle
titers were representative of viral activities. Ear thickness was
measured immediately prior to and every 24 h through 72 h after
injection using an engineer's micrometer (Mitutoyo model 7326). Ear
measurements are reported in units of 10−4 in. Ears that developed
hematomas were excluded. Data represent the average values after
subtraction of swelling induced by injection of buffer alone±the
standard error of the mean. Swelling induced by injection of ears with
buffer alone averaged 4.80±0.237 units. Statistical signiﬁcance was
determined using the two-tailed T test.
Acknowledgments
We thank Ana Ruiz for technical assistance, David Orlicky for
advice and the gift of a plasmid encoding the SV40 poly A site, andMK
Smith and the Kathryn Holmes laboratory for assistance in capturing
plaque images. This work was supported by a grant from the
University of Colorado Technology Transfer Ofﬁce.
All authors declare no actual or potential conﬂict of interest.
The funding agency had no role other than ﬁnancial support in this
study.
References
Chatterjee, P.K., Vayda, M.E., Flint, S.J., 1986. Adenoviral protein VII packages
intracellular viral DNA throughout the early phase of infection. EMBO J. 5,
1633–1644.
Chen, H.H., Mack, L.M., Kelly, R., Ontell, M., Kochanek, S., Clemens, P.R., 1997.
Persistence in muscle of an adenoviral vector that lacks all viral genes. Proc. Natl
Acad. Sci. USA 94, 1645–1650.
Chen, J., Morral, N., Engel, D.A., 2007. Transcription releases protein VII from adenovirus
chromatin. Virology 369, 411–422.
Choi, H., Park, J.Y., Coonrod, L., Sun, J., Kaleko, M., 1993. Adenovirus mediated
expression of therapeutic plasma levels of human factor IX in mice. Nat. Genet. 5,
397–402.
Clemens, P.R., Kochanek, S., Sunada, Y., Chan, S., Chen, H.H., Campbell, K.P., Caskey, C.T.,
1996. In vivo muscle gene transfer of full-length dystrophin with an adenoviral
vector that lacks all viral genes. Gene Ther. 3, 965–972.
Crossland, L.D., Raskas, H.J., 1983. Identiﬁcation of adenovirus genes that require
template replication for expression. J. Virol. 46, 737–748.
Ding, E., Hu, H., Hodges, B.L., Migone, F., Serra, D., Xu, F., Chen, Y.T., Amalﬁtano, A., 2002.
Efﬁcacy of gene therapy for a prototypical lysosomal storage disease (GSD-II) is
critically dependent on vector dose, transgene promoter, and the tissues targeted
for vector transduction. Mol. Ther. 5, 436–446.
Graham, F.L., Smiley, J., Russell, W.C., Nairn, R., 1977. Characteristics of a human cell line
transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59–72.
35J. Schaack et al. / Virology 412 (2011) 28–35He, T.C., Zhou, S., da Costa, L.T., Yu, J., Kinzler, K.W., Vogelstein, B., 1998. A simpliﬁed
system for generating recombinant adenoviruses. Proc. Natl Acad. Sci. USA 95,
2509–2514.
Hearing, P., Shenk, T., 1983. The adenovirus type 5 E1A transcriptional control region
contains a duplicated enhancer element. Cell 33, 695–703.
Horwitz, M.S., 2004. Function of adenovirus E3 proteins: their interactions with
immunoregulatory cell proteins. J. Gene Med. 6 (Suppl 1), S172–S183.
Janaswami, P.M., Kalvakolanu, D.V., Zhang, Y., Sen, G.C., 1992. Transcriptional
repression of interleukin-6 gene by adenoviral E1A proteins. J. Biol. Chem. 267,
24886–24891.
Jordan, M., Schallhorn, A., Wurm, F.M., 1996. Transfecting mammalian cells:
optimization of critical parameters affecting calcium-phosphate precipitate
formation. Nucleic Acids Res. 24, 596–601.
Kessler, P.D., Podsakoff, G.M., Chen, X., McQuiston, S.A., Colosi, P.C., Matelis, L.A.,
Kurtzman, G.J., Byrne, B.J., 1996. Gene delivery to skeletal muscle results in
sustained expression and systemic delivery of a therapeutic protein. Proc. Natl
Acad. Sci. USA 93, 14082–14087.
Kozak, M., 1987. An analysis of 5'-noncoding sequences from 699 vertebrate messenger
RNAs. Nucleic Acids Res. 15, 8125–8148.
Lichtenstein, D.L., Toth, K., Doronin, K., Tollefson, A.E., Wold, W.S., 2004. Functions and
mechanisms of action of the adenovirus E3 proteins. Int. Rev. Immunol. 23, 75–111.
Lichtenstein, D.L., Wold, W.S., 2004. Experimental infections of humans with wild-type
adenoviruses with replication-competent adenovirus vectors: replication, safety,
transmission. Cancer Gene Ther. 10, 1–11.
Liu, C.C., Simonsen, C.C., Levinson, A.D., 1984. Initiation of translation at internal AUG
codons in mammalian cells. Nature 309, 82–85.
Moorhead, J.W., Clayton, G.H., Smith, R.L., Schaack, J., 1999. An adenovirus vector
deleted for the preterminal protein gene elicits reduced inﬂammation in mouse
ears. J. Virol. 73, 1046–1053.
Morsy, M.A., Gu, M., Motzel, S., Zhao, J., Lin, J., Su, Q., Allen, H., Franlin, L., Parks, R.J.,
Graham, F.L., Kochanek, S., Bett, A.J., Caskey, C.T., 1998. An adenoviral vector deleted
for all viral coding sequences results in enhanced safety extended expression of a
leptin transgene. Proc. Natl Acad. Sci. USA 95, 7866–7871.
Muruve, D.A., Barnes, M.J., Stillman, I.E., Libermann, T.A., 1999. Adenoviral gene therapy
leads to rapid induction of multiple chemokines acute neutrophil-dependent
hepatic injury in vivo. Hum. Gene Ther. 10, 965–976.
Muruve, D.A., Cotter, M.J., Zaiss, A.K., White, L.R., Liu, Q., Chan, T., Clark, S.A., Ross, P.J.,
Meulenbroek, R.A., Maelandsmo, G.M., Parks, R.J., 2004. Helper-dependent
adenovirus vectors elicit intact innate but attenuated adaptive host immune
responses in vivo. J. Virol. 78, 5966–5972.
Nakai, M., Komiya, K., Murata, M., Kimura, T., Kanaoka, M., Kanegae, Y., Saito, I., 2007.
Expression of pIX gene induced by transgene promoter: possible cause of host
immune response in ﬁrst-generation adenoviral vectors. Hum. Gene Ther. 18,
925–936.
Nitzsche, A., Paulus, C., Nevels, M., 2008. Temporal dynamics of cytomegalovirus
chromatin assembly in productively infected human cells. J. Virol. 82,
11167–11180.
Orlicky, D.J., Schaack, J., 2001. Adenovirus transduction of 3T3-L1 cells. J. Lipid Res. 42,
460–466.
Parks, C.L., Spector, D.J., 1990. cis-dominant defect in activation of adenovirus type 5
E1b early RNA synthesis. J. Virol. 64, 2780–2787.
Pastore, L., Morral, N., Zhou, H., Garcia, R., Parks, R.J., Kochanek, S., Graham, F.L., Lee, B.,
Beaudet, A.L., 1999. Use of a liver-speciﬁc promoter reduces immune response to
the transgene in adenoviral vectors. Hum. Gene Ther. 10, 1773–1781.Reich, N., Pine, R., Levy, D., Darnell Jr., J.E., 1988. Transcription of interferon-stimulated
genes is induced by adenovirus particles but is suppressed by E1A gene products.
J. Virol. 62, 114–119.
Rolling, F., Nong, Z., Pisvin, S., Collen, D., 1997. Adeno-associated virus-mediated gene
transfer into rat carotid arteries. Gene Ther. 4, 757–761.
Schaack, J., 2005. Induction and inhibition of innate inﬂammatory responses by
adenovirus early region proteins. Viral Immunol. 18, 79–88.
Schaack, J., Allen, B., Orlicky, D.J., Bennett, M.L., Maxwell, I.H., Smith, R.L., 2001.
Promoter strength in adenovirus transducing vectors: down-regulation of the
adenovirus E1A promoter in 293 cells facilitates vector construction. Virology 291,
101–109.
Schaack, J., Bennett, M.L., Colbert, J.D., Torres, A.V., Clayton, G.H., Ornelles, D., Moorhead,
J., 2004. E1A and E1B proteins inhibit inﬂammation induced by adenovirus. Proc.
Natl Acad. Sci. USA 101, 3124–3129.
Schaack, J., Guo, X., Ho, W.Y., Karlok, M., Chen, C., Ornelles, D., 1995. Adenovirus type 5
precursor terminal protein-expressing 293 and HeLa cell lines. J. Virol. 69,
4079–4085.
Shapiro, G.S., VanPeursem, C., Ornelles, D.A., Schaack, J., DeGregori, J., 2006. Adenoviral
vectors utilizing the cytomegalovirus promoter induce the expression of p73 via
the E4-orf6/7 protein. J. Virol. 80, 5349–5360.
Shen, L., Spector, D.J., 2003. Local character of readthrough activation in adenovirus
type 5 early region 1 transcription control. J. Virol. 77, 9266–9277.
Smith, T.A., Mehaffey, M.G., Kayda, D.B., Saunders, J.M., Yei, S., Trapnell, B.C., McClelland,
A., Kaleko, M., 1993. Adenovirus mediated expression of therapeutic plasma levels
of human factor IX in mice. Nat. Genet. 5, 397–402.
Straus, S.E., 1984. Adenovirus infections in humans. In: Ginsberg, H.S. (Ed.), The
Adenoviruses. Plenum, New York, pp. 451–496.
Takeda, T., Nakajima, K., Kojima, H., Hirano, T., 1994. E1A repression of IL-6-induced
gene activation by blocking the assembly of IL-6 response element binding
complexes. J. Immunol. 153, 4573–4582.
Toietta, G., Mane, V.P., Norona, W.S., Finegold, M.J., Ng, P., McDonagh, A.F., Beaudet, A.L.,
Lee, B., 2005. Lifelong elimination of hyperbilirubinemia in the Gunn rat with a
single injection of helper-dependent adenoviral vector. Proc. Natl Acad. Sci. USA
102, 3930–3935.
Vales, L.D., Darnell, J.E.J., 1989. Promoter occlusion prevents transcription of adenovirus
polypeptide IX mRNA until after DNA replication. Genes Dev. 3, 49–59.
Wasylyk, B., Wasylyk, C., Chambon, P., 1984. Short and long range activation by the
SV40 enhancer. Nucleic Acids Res. 12, 5589–5608.
Windheim, M., Hilgendorf, A., Burgert, H.G., 2004. Immune evasion by adenovirus E3
proteins: exploitation of intracellular trafﬁcking pathways. Curr. Top. Microbiol.
Immunol. 273, 29–85.
Yang, Y., Jooss, K.U., Su, Q., Ertl, H.C., Wilson, J.M., 1996. Immune responses to viral
antigens versus transgene product in the elimination of recombinant adenovirus-
infected hepatocytes in vivo. Gene Ther. 3, 137–144.
Yang, Y., Nunes, F.A., Berencsi, K., Furth, E.E., Gönczöl, E., Wilson, J.M., 1994. Cellular
immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc.
Natl. Acad. Sci. USA. Cellular immunity to viral antigens limits E1-deleted
adenoviruses for gene therapy. Proc. Natl Acad. Sci. USA 91, 4407–4411.
Zenke, M., Grundström, T., Matthes, H., Wintzerith, M., Schatz, C., Wildeman, A.,
Chambon, P., 1986. Multiple sequence motifs are involved in SV40 enhancer
function. EMBO J. 5, 387–397.
Zhang, Y., Chirmule, N., Gao, G.P., Qian, R., Croyle, M., Joshi, B., Tazelaar, J., Wilson, J.M.,
2001. Acute cytokine response to systemic adenoviral vectors in mice is mediated
by dendritic cells macrophages. Mol. Ther. 3, 697–707.
